Seqirus UK Ltd: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyMaidenheadNationwide (UK)Main market: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

Companies House09614642 ↗ · Active

Where they win
i

32 awards (31 for a named lot, 97%, 1 for a whole procedure with no lot named) · top CPV classes, shares of all 32 awards. An award may cover more than one class.

3360 Pharmaceutical products9 awards · 28% · 8 awards naming a lot + 1 whole-procedure awards
Attributable award value
i
£159mOn 23 of 32 award records; the five largest make 51%. Largest rows below.
Typical attributable award
i
£5.2m middle valuerobust · n=23
Award vs estimate
i

Based on 7 wins in its industry (CPV division 33).

0% at estimaterobust · n=7compared within CPV division 33

Where their buyers are
i

ITL1 region of the buyer office · known for 27 of 27 awarded procedures · each procedure counts once

Greater London9 procedures · 33%
Scotland9 procedures · 33%
Northern Ireland4 procedures · 15%
Wales (Cymru)2 procedures · 7%
North West England1 procedure · 4%
Yorkshire and the Humber1 procedure · 4%
South West England1 procedure · 4%

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health81%(26 awards)
    26 of 32 awards are NHS & health (81%).
  • Type not classified16%(5 awards)
    5 of 32 awards are Type not classified (16%).
  • Central government3%(1 award)
    1 of 32 awards is Central government (3%).

Share = of the 27 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

18 of 32 awards carry an end date, 11 estimated from the duration · not a retender forecast

ContractEndsPublished value
Flu Vaccines for Over-65s as recommended by JCVI for 2026/2713 Dec 2026 estimated£9,607,615
Flu Vaccines for Under-65s as recommended by JCVI for 2026/2713 Dec 2026 estimated£5,216,899
Inactivated influenza vaccine for children 202523 Mar 2028 estimated£1

Recent awards

Latest 30 of 32 award records naming this supplier

Award / procedureAuthorityAwardedPublished value
YAS 368 2025_26 Seqirus Vaccines Ltd – Flu vaccinesYorkshire Ambulance Service NHS Trust13 Mar 2026£34,658
Seasonal Influenza Vaccines 2026/2027Regional Business Services Organisation Procurement and Logistics ServiceNot published£5,037,766 †
from the contract notice
Flu Vaccines for Over-65s as recommended by JCVI for 2026/27The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£9,607,615 †
from the contract notice
Flu Vaccines for Under-65s as recommended by JCVI for 2026/27The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£5,216,899 †
from the contract notice
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Seasonal Influenza Vaccines 2025/26Regional Business Services Organisation Procurement and Logistics ServiceNot published£5,166,140 †
from the contract notice
Inactivated influenza vaccine for children 2025Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security AgencyNot published£1 †
from the contract notice
Influenza Vaccines for persons aged 18 to 64 years, as recommended by JCVI for 2025/26The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£5,670,000 †
from the contract notice
Influenza Vaccine for adults aged 65 years and above as recommended by JCVI for 2025/26The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£9,230,000 †
from the contract notice
Influenza Vaccine Season 2025NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)Not published£32,078,880 †
from the contract notice
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 7 of 32 awards, estimated from the published duration on 11 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.